Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Debt / NOTE 2.750%10/0
-
Market price (% of par)
-
347.32%
-
Total 13F principal
-
$52,326,000
-
Principal change
-
-$10,945,000
-
Total reported market value
-
$181,360,000
-
Number of holders
-
9
-
Value change
-
-$40,201,392
-
Number of buys
-
1
-
Number of sells
-
4
Institutional Holders of ISIS PHARMACEUTICALS INC DEL - NOTE 2.750%10/0 as of Q2 2015
As of 30 Jun 2015,
ISIS PHARMACEUTICALS INC DEL - NOTE 2.750%10/0 was held by
9 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$52,326,000
in principal (par value) of the bond.
The largest 9 bondholders included
WOLVERINE ASSET MANAGEMENT LLC, WHITEBOX ADVISORS LLC, Fore Research & Management, LP, FMR LLC, Nantahala Capital Management, LLC, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, Integrated Wealth Management, and MANAGED ACCOUNT ADVISORS LLC.
This page lists
9
institutional bondholders reporting positions
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.